Charles E. Rupprecht

Novel Paramyxoviruses in Bats from Sub-Saharan Africa, 2007-2012.

Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention.

Diversity and phylogenetic relationships among Bartonella strains from Thai bats.

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus.

SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.

FIELD TRIALS OF ONTARIO RABIES VACCINE BAIT IN THE NORTHEASTERN USA, 2012-14.

Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis.

Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination.

A Perspective on Rabies in the Middle East-Beyond Neglect.

Erratum: Rupprecht, C.E., et al. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. 2018, , 59.

Correction to: Oral vaccination of dogs: a well-studied and undervalued tool for achieving human and dog rabies elimination.

In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants.

Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment.

Rabies in the Caribbean: A Situational Analysis and Historic Review.

Priorities in applied research to ensure programmatic success in the global elimination of canine rabies.

Avoiding preventable deaths: The scourge of counterfeit rabies vaccines.

Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination.

Improving human rabies post-exposure prophylaxis.

SAFETY, IMMUNOGENICITY, AND EFFICACY OF INTRAMUSCULAR AND ORAL DELIVERY OF ERA-G333 RECOMBINANT RABIES VIRUS VACCINE TO BIG BROWN BATS ().

Towards rabies elimination in the Asia-Pacific region: From theory to practice.

In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models.

Modern biologics for rabies prophylaxis and the elimination of human cases mediated by dogs.

Notes on three periods of rabies focus in the Middle East: From progress during the cradle of civilization to neglected current history.

Update on lyssaviruses and rabies: will past progress play as prologue in the near term towards future elimination?

Towards Development of an Anti-Vampire Bat Vaccine for Rabies Management: Inoculation of Vampire Bat Saliva Induces Immune-Mediated Resistance.

Rabies in Costa Rica - Next Steps Towards Controlling Bat-Borne Rabies After its Elimination in Dogs.

The Rabies Concert: Rising towards the Last Waltz?

Rabies in a Sand Cat (Felis margarita) in Saudi Arabia: One Health Implications.

Rabies epidemiology, prevention and control in Nigeria: Scoping progress towards elimination.

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis.

Renewed Public Health Threat from Emerging Lyssaviruses.

Spatiotemporal heterogeneity and determinants of canine rabies evidence at Local Government Area Level in Nigeria: Implications for rabies prevention and control.

Rabies in the Tropics.

A One Medicine Mission for an Effective Rabies Therapy.

COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria.

Special Issue "Innovative Techniques and Approaches in the Control and Prevention of Rabies Virus".

Time to Revise the WHO Categories for Severe Rabies Virus Exposures-Category IV?